ADAPT-2 Trial Results Deliver a Breakthrough in Long Search for Methamphetamine Use Disorder Medication
A combination of bupropion and naltrexone successfully reduced methamphetamine use.
Nora's Blog
|
NIDA-funded research aims to help understand teen drug use and its effects
On World AIDS Day, Celebrating Scientific Advances and Confronting the Complexities of HIV and Substance Use
|
We applaud the substantial strides made, while recognizing the challenges that need to be addressed.
|
There is an alarming increase in deaths involving the stimulant drugs methamphetamine and cocaine.
7 Comments
|
People with SUDs may be particularly vulnerable to COVID-19 and its most adverse health outcomes
Addressing the Unique Challenges of COVID-19 for People in Recovery
|
Significant increases in many kinds of drug use have been recorded since March
Research at the Intersection of HIV with Substance Use Disorders amidst the COVID-19 Pandemic
|
We are prioritizing research into how the coexisting crises of COVID-19, HIV, and substance use, including the opioid crisis, combine to create a disastrous storm, taking lives and overtaxing America’s...
NIDA Seeks Public Input for Our 2021-2025 Strategic Plan
|
NIDA has begun drafting its strategic plan for 2021-2025, and to best inform that process, we are seeking input from the public and the scientific community.
NIDA Researchers Adapt Their Projects to Study COVID-19
|
The U.S. is now facing two intersecting health crises, the ongoing opioid overdose epidemic and the COVID-19 pandemic. Regrettably, each has the potential to exacerbate the effects of the other.
|
We know that science itself is at its best when it is most inclusive, and humans are best when we embrace diversity. Conversations about systemic racial inequalities can be uncomfortable...
|
Healthcare already has effective tools including medications for opioid and alcohol use disorder, but they are not being utilized widely enough. One important reason is the stigma that surrounds people...
